G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination

Table 3 Proportion of G6PD deficiency among malaria-infected populations in the combined sample of two national groups, Myanmar (2016-2018)

Malaria status	G6PD RDT negative (G6PD normal)	G6PD RDT positive (G6PD deficiency)	Combined study population
Malaria RDT negative	253	25	278
Malaria RDT positive	35	7 (16.7%)^a	42
Malaria PCR negative	231	22	253
Malaria PCR positive	57	10 (14.9%)^b	67

^aPearson chi-square value = 2.38, p = 0.122, ^bPearson chi-square value = 2.28, p = 0.13

ISSN: 1349-4147